Loading organizations...
§ Private Profile · South San Francisco, CA, USA
Medical device developer creating synthetic cartilage biomaterials for orthopaedics, focused on repairing cartilage damage.
Biomimedica is a medical device startup based in South San Francisco, California, and Germantown, Tennessee, that develops and commercializes proprietary synthetic cartilage technology for orthopedic joint repair. The company utilizes biocompatible hydrogels to create its GRADION Total Cartilage Replacement system, which is designed to mimic the mechanics, lubrication, and durability of natural human cartilage. This innovative biomaterial technology specifically targets orthopedic surgeons and healthcare providers treating patients who suffer from osteoarthritis, joint degeneration, and severe sports injuries. Operating as a pre-revenue research enterprise, the firm has raised a total of $17.37 million in equity financing, which includes an $11.9 million Series B funding round. Led by CEO Jeff Roberts, the venture-backed business was founded in 2007 by David Myung and Curtis Frank to commercialize foundational hydrogel research originating at Stanford University, with early investment support from Emergent Medical Partners.
Biomimedica has raised $14.3M across 2 funding rounds.
Biomimedica has raised $14.3M in total across 2 funding rounds.
Biomimedica has raised $14.3M across 2 funding rounds. Most recently, it raised $11.9M Series B in June 2012.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 21, 2012 | $11.9M Series B | Artyom Yukhin | Asset Management Ventures, Biedermann Motech, Emergent Medical Partners | Announced |
| Jun 18, 2008 | $2.4M Venture Round | Emergent Medical Partners | Asset Management, Life Science Angels | Announced |
Biomimedica has raised $14.3M in total across 2 funding rounds.
Biomimedica's investors include Artyom Yukhin, Asset Management Ventures, Biedermann Motech, Emergent Medical Partners, Asset Management, Life Science Angels.